DE2033702A1 - Heilmittel - Google Patents

Heilmittel

Info

Publication number
DE2033702A1
DE2033702A1 DE19702033702 DE2033702A DE2033702A1 DE 2033702 A1 DE2033702 A1 DE 2033702A1 DE 19702033702 DE19702033702 DE 19702033702 DE 2033702 A DE2033702 A DE 2033702A DE 2033702 A1 DE2033702 A1 DE 2033702A1
Authority
DE
Germany
Prior art keywords
chloro
dihydro
phenyl
methyl
dibenzo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19702033702
Other languages
German (de)
English (en)
Inventor
Jacques Allschwil Babel (Schweiz)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE2033702A1 publication Critical patent/DE2033702A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19702033702 1969-07-21 1970-07-07 Heilmittel Pending DE2033702A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1109969 1969-07-21

Publications (1)

Publication Number Publication Date
DE2033702A1 true DE2033702A1 (de) 1971-02-04

Family

ID=4370039

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19702033702 Pending DE2033702A1 (de) 1969-07-21 1970-07-07 Heilmittel

Country Status (12)

Country Link
AT (1) AT297217B (https=)
BE (1) BE753598A (https=)
CA (1) CA946287A (https=)
DE (1) DE2033702A1 (https=)
ES (1) ES382000A1 (https=)
FR (1) FR2059536B1 (https=)
GB (1) GB1305738A (https=)
IE (1) IE34397B1 (https=)
IL (1) IL34903A0 (https=)
MY (1) MY7500273A (https=)
NL (1) NL164745C (https=)
ZA (1) ZA704677B (https=)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL136835C (https=) * 1965-12-03

Also Published As

Publication number Publication date
AT297217B (de) 1972-03-10
IE34397L (en) 1971-01-21
CA946287A (en) 1974-04-30
IE34397B1 (en) 1975-04-30
NL164745C (nl) 1981-02-16
NL7009462A (https=) 1971-01-25
ES382000A1 (es) 1974-12-16
GB1305738A (https=) 1973-02-07
FR2059536B1 (https=) 1973-08-10
IL34903A0 (en) 1970-09-17
ZA704677B (en) 1971-05-27
NL164745B (nl) 1980-09-15
FR2059536A1 (https=) 1971-06-04
MY7500273A (en) 1975-12-31
BE753598A (fr) 1971-01-18

Similar Documents

Publication Publication Date Title
DE69327585T2 (de) Befruchtete muscheleier enthaltende zusammensetzung
DE2856393C2 (de) Arzneimittel zur Behandlung von Morbus Parkinson
DE3338995C2 (https=)
DE69624699T2 (de) Hochdosiertes chromtripicolinat zur behandlung von typ-ii-diabetes
DE3040780C2 (de) Verwendung einer pharmazeutischen Zusammensetzung zur Behandlung von Diabetes
DE69612510T2 (de) Verwendung von 1-(2-naphtylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridin zur herstellung eines medikaments zur behandlung der amyotrophen lateralsklerode
DE2823174A1 (de) Arzneimittel fuer die prophylaktische behandlung postoperativer tiefer venenthrombose
DE3490399T1 (de) Pharmazeutische Präparate mit appetitmindernder Wirkung und Verfahren zu deren Herstellung
DE2824165A1 (de) Arzneimittel mit angstneurosen und angstaehnliche neurosen beseitigender wirkung und verfahren zum zubereiten des arzneimittels
EP0176769A2 (de) Carcinom-Therapeutikum
DE2033702A1 (de) Heilmittel
DE2525064C2 (de) Arzneimittel mit Antiparkinson-Wirkung
DE69325512T2 (de) Verwendung von remacemid zur behandlung des morbus parkinson
DE3213579C2 (https=)
CH660303A5 (de) Analgetische praeparate.
DE1617508C3 (de) Antidepressive Mittel
DE2422612C3 (de) .Verwendung von 2,6-trans-Diphenylhexamethylcyclotetrasiloxan zur Herstellung eines oral oder intravenös verabreichbaren Arzneimittels zur Erhöhung des Dopamingehalts fan Gehirn von Tieren
WO1998052548A2 (de) Verwendung von 1-ar(alk)yl-imidazolin-2-one zur behandlung von angst- und spannungszuständen
DE3048700C2 (de) Pharmazeutische Zubereitung zur Verbesserung des Lipidstoffwechsels
DE1941583C3 (de) Analgeticum
DE102020106962B4 (de) Kombinationspräparat für die antipsychotische Therapie
DE2004281C3 (de) Vasodilatatorisches Mittel
DE3872571T2 (de) Mischung mit einem gehalt an einem zentralanalgetikum und forskolin als wirkstoffe.
CH658389A5 (de) Pharmazeutisches mittel fuer prophylaxe und behandlung von arteriosklerose.
DE3439055A1 (de) Substituierte 4h-3,1 benzoxazine und ein benzodiazepin-derivat enthaltendes arzneimittel